Sarissa Capital Management LP Portfolio Holdings

Sarissa Capital Management LP

  • $402 Million
  • Q3 2024

Sarissa Capital Management LP has filed its 13F form on November 14, 2024 for Q3 2024 where it was disclosed a total value porftolio of $402 Million distributed in 10 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Innoviva, Inc. with a value of $140M, Ironwood Pharmaceuticals Inc with a value of $67.4M, Gilead Sciences, Inc. with a value of $64M, Cytokinetics Inc with a value of $58.6M, and Neurocrine Biosciences Inc with a value of $47.3M.

Examining the 13F form we can see an decrease of $190M in the current position value, from $592M to 402M.

Sarissa Capital Management LP is based out at Greenwich, CT

Below you can find more details about Sarissa Capital Management LP portfolio as well as his latest detailed transactions.

Portfolio value $402 Million
Healthcare: $402 Million

Stock Holdings Table Market Cap. of $50 Millions to $300 Millions

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History
$222M
$15.7 Million 3.89% of portfolio
24,850,623
Q4 2023 Added 137.98%

Summary

  • Portfolio
  • No. of Stocks 10
  • Current Value $402 Million
  • Prior Value $592 Million
  • Filing
  • Period Q3 2024
  • Filing Date November 14, 2024
  • Form Type 13F-HR
  • Activity in Q3 2024
  • New Purchases 1 stocks
  • Additional Purchases 0 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 2 stocks
Track This Portfolio

Track Sarissa Capital Management LP Portfolio

Follow Sarissa Capital Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sarissa Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Sarissa Capital Management LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email